Search by Drug Name or NDC
NDC 00409-4278-01 Lidocaine Hydrochloride 5 mg/mL Details
Lidocaine Hydrochloride 5 mg/mL
Lidocaine Hydrochloride is a INFILTRATION; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-4278 |
|---|---|
| Product ID | 0409-4278_1d346dc9-3408-4971-8cd5-79c2527eee5f |
| Associated GPIs | 69100040102006 |
| GCN Sequence Number | 060677 |
| GCN Sequence Number Description | lidocaine HCl/PF VIAL 5 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 26888 |
| HICL Sequence Number | 033592 |
| HICL Sequence Number Description | LIDOCAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LIDOCAINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INFILTRATION; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA088328 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-4278-01 (00409427801)
| NDC Package Code | 0409-4278-01 |
|---|---|
| Billing NDC | 00409427801 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4278-01) / 50 mL in 1 VIAL, SINGLE-DOSE (0409-4278-16) |
| Marketing Start Date | 2005-06-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |